Baxter International | BAX - Current Assets


Baxter International reported $6.87B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
AngioDynamics USD 172.27M 3.09M Feb/2025
Artivion USD 337.5M 18.68M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Avanos Medical USD 351.4M 4.6M Sep/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
ICU Medical USD 1.19B 16.74M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Masimo USD 1.05B 221.5M Sep/2025
Medtronic USD 24B 773M Sep/2025
Merit Medical Systems USD 985.53M 62.46M Sep/2025
Quest Diagnostics USD 2.38B 29M Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.99B 262.12M Sep/2025
Terumo JPY 815.56B 71.48B Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025